Cronos Group Inc., a Canadian pot producer partially owned by cigarette maker
Thomas Cohn, who spent the past year as general counsel for privately held consumer products company Avon Co. in New York, confirmed in an email to Bloomberg Law that he recently joined Cronos as head of regulatory and product.
Cronos sought FTC and Food and Drug Administration expertise for “building disruptive intellectual property by advancing cannabis research, technology, and product development,” according to an online job posting ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.